GAMROZYNE is a fast-acting, long-acting macrolide antibiotic, offering veterinary surgeons a convenient, single-dose treatment option across three livestock species. Its active ingredient, gamithromycin, is rapidly absorbed following administration and achieves sustained concentrations in target tissues, supporting its use in the management of susceptible bacterial infections.
Respiratory disease continues to present a significant challenge to livestock health, welfare and productivity. In cattle and pigs, bacterial respiratory infections can contribute to reduced performance, increased veterinary intervention and economic losses. Similarly, infectious foot rot in sheep can cause considerable pain, lameness and welfare concerns, reinforcing the importance of timely diagnosis and effective veterinary treatment.
This latest launch further strengthens Bimeda's growing portfolio of licensed farm animal medicines, providing veterinary surgeons with an additional treatment option that combines rapid absorption, prolonged tissue exposure and practical administration.
Rachel Mallet, Technical & Commercial Veterinarian for Bimeda® UK, comments: “GAMROZYNE is another exciting addition to our expanding farm animal portfolio, and we're delighted to introduce this treatment option to the UK veterinary market. Respiratory disease and lameness continue to present significant challenges to livestock health and welfare. Where prevention has been unsuccessful, and antimicrobials are indicated, Gamrozyne offers a solution which actively accumulates in the target tissue and reaches therapeutic lung concentrations just 30 minutes after administration. Thanks to this accumulation effect, it offers long activity while inflamed tissues return to normal, preventing immediate reoccurrence. At Bimeda, we remain committed to supporting farm vets through continued innovation and the introduction of high-quality, accessible medicines that meet the needs of veterinary professionals and ultimately benefit animal health and welfare.”
Veterinary surgeons wishing to find out more can contact Bimeda® on 01248 725400 or uksales@bimeda.com.
GAMROZYNE is available in a 100 ml presentation. Use of GAMROZYNE should follow the Summary of Product Characteristics (SPC), available through the Veterinary Medicines Directorate (VMD). Prescription decisions are for the person issuing the prescription alone.
About Bimeda®
Bimeda® is a global leader in animal health, supplying high-quality veterinary pharmaceuticals and animal health products in more than 80 countries. Its mission is to support veterinarians and producers with effective, science-based solutions that promote animal well-being and sustainable production. Use medicines responsibly. Noah.co.uk/responsible.
Product information: https://www.bimeda.co.uk/bimeda-prod...il/gamrozyne-t
Website: https://www.bimeda.co.uk/
Attached Files